Evidence map›Paper›PMID 41216524›Full record

ArticleHeliyon2025

Corrigendum to "A new 1D Mn(II) coordination polymer: Synthesis, crystal structure, hirshfeld surface analysis and molecular docking studies" [Heliyon Volume 10, Issue 8, April 2024, Article e29565].

Atash V Gurbanov, Fateme Firoozbakht, Nafiseh Pourshirband, Paria Sharafi-Badr, Payam Hayati, Bagher Souri, Fazlolah Eshghi, Werner Kaminsky, Ghodrat Mahmoudi, Francis Verpoort and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Atash V GurbanovCentro de Química Estrutural, Institute of Molecular Sciences, Instituto Superior T'ecnico, Universidade de Lisboa, Av. Rovisco Pais, 1049-001, Lisboa, Portugal.
Fateme FiroozbakhtDepartment of Chemistry, University of Isfahan, Isfahan, 81746-73441, Iran.
Nafiseh PourshirbandDepartment of Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box 311-86145, Shahreza, Isfahan, Iran.
Paria Sharafi-BadrDepartment of Pharmacognosy and Pharmaceutical Biotechnology, School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran.
Payam HayatiOrganic and Nano Group (ONG), Department of Chemistry, Iran University of Science and Technology (IUST), PO Box 16846-13114, Tehran, Iran.
Bagher SouriDepartment of Chemistry, Faculty of Sciences, University of Sistan and Baluchestan, Zahedan, Iran.
Fazlolah EshghiDepartment of Chemistry, College of Sciences, Shiraz University, Shiraz, Iran.
Werner KaminskyX-ray Crystallography Laboratory, University of Washington, United States.
Ghodrat MahmoudiDepartment of Chemistry, Faculty of Science, University of Maragheh, P.O. Box 55136-83111, Maragheh, Iran.
Francis VerpoortState Key Laboratory of Advanced Technology for Materials Synthesis and Processing, Wuhan University of Technology, Wuhan, 430070, China.
Zohreh MehrabadiDepartment of Chemistry, Firoozabad Branch, Islamic Azad University, Firoozabad, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1016/j.heliyon.2024.e29565.].

Identifiers

PMID41216524
PMCPMC12281374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.